276 research outputs found

    Tailoring CD19xCD3-DART exposure enhances T-cells to eradication of B-cell neoplasms.

    Get PDF
    Many patients with B-cell malignancies can be successfully treated, although tumor eradication is rarely achieved. T-cell-directed killing of tumor cells using engineered T-cells or bispecific antibodies is a promising approach for the treatment of hematologic malignancies. We investigated the efficacy of CD19xCD3 DART bispecific antibody in a broad panel of human primary B-cell malignancies. The CD19xCD3 DART identified 2 distinct subsets of patients, in which the neoplastic lymphocytes were eliminated with rapid or slow kinetics. Delayed responses were always overcome by a prolonged or repeated DART exposure. Both CD4 and CD8 effector cytotoxic cells were generated, and DART-mediated killing of CD4+ cells into cytotoxic effectors required the presence of CD8+ cells. Serial exposures to DART led to the exponential expansion of CD4 + and CD8 + cells and to the sequential ablation of neoplastic cells in absence of a PD-L1-mediated exhaustion. Lastly, patient-derived neoplastic B-cells (B-Acute Lymphoblast Leukemia and Diffuse Large B Cell Lymphoma) could be proficiently eradicated in a xenograft mouse model by DART-armed cytokine induced killer (CIK) cells. Collectively, patient tailored DART exposures can result in the effective elimination of CD19 positive leukemia and B-cell lymphoma and the association of bispecific antibodies with unmatched CIK cells represents an effective modality for the treatment of CD19 positive leukemia/lymphoma

    Effects of feeding low fishmeal diets with increasing soybean meal levels on growth, gut histology and plasma biochemistry of sea bass

    Get PDF
    The aquaculture industry depends upon the development of sustainable protein sources to replace fishmeal (FM) in aquafeeds and the products derived from soybeans are some of the most studied plant feedstuffs. A key area of investigation for continuing to improve modern aquafeeds includes the evaluation of varying proportions and combinations of plant ingredients to identify mixtures that are more efficiently utilized by the fish. This study investigated the effects of increasing soybean meal (SBM) by replacing a mix of plant ingredients in low FM (20%) diets on growth, blood biochemistry profile and gut histology on European sea bass. Five isonitrogenous and isolipidic experimental diets were formulated: four diets containing increasing SBM levels (0, 10, 20 and 30%; 0SBM, 10SBM, 20SBM and 30SBM, respectively) with a low content of FM (20%) and one control diet (0% SBM; 35% FM). Diets containing SBM brought to comparable performance and protein utilization, while 0SBM had negative impact on feed conversion rate and protein utilization. Blood parameters suggested an optimal nutritional status under all feeding treatments, even though slightly decreased values were reported at increasing dietary SBM. Histology examination did not show any changes indicative of soy-induced enteritis. We can conclude that for European sea bass: (i) different blends of plant protein did not affect feed intake despite the 20% FM dietary level; (ii) the inclusion of SBM maintains optimal growth and feed utilization in low FM diets; (iii) blood biochemistry profile showed a good nutritional status under all feeding regimes; (iv) no evidence of soy-induced enteritis was reported in any group fed low FM diets. For formulation of practical diets in on-growing of European sea bass, SBM up to 30% can be successfully incorporated into feeds containing low FM inclusion

    NLL soft and Coulomb resummation for squark and gluino production at the LHC

    Get PDF
    We present predictions of the total cross sections for pair production of squarks and gluinos at the LHC, including the stop-antistop production process. Our calculation supplements full fixed-order NLO predictions with resummation of threshold logarithms and Coulomb singularities at next-to-leading logarithmic (NLL) accuracy, including bound-state effects. The numerical effect of higher-order Coulomb terms can be as big or larger than that of soft-gluon corrections. For a selection of benchmark points accessible with data from the 2010-2012 LHC runs, resummation leads to an enhancement of the total inclusive squark and gluino production cross section in the 15-30 % range. For individual production processes of gluinos, the corrections can be much larger. The theoretical uncertainty in the prediction of the hard-scattering cross sections is typically reduced to the 10 % level.Comment: 45 pages, 16 Figures, LaTex. v2: published version. Grids with numerical results for the NLL cross sections for squark and gluino production at the 7/8 TeV LHC are included in the submission and are also available at http://omnibus.uni-freiburg.de/~cs1010/susy.htm

    Development and Preliminary Clinical Activity of PD-1-Guided CTLA-4 Blocking Bispecific DART Molecule.

    Get PDF
    Combination immunotherapy with antibodies directed against PD-1 and CTLA-4 shows improved clinical benefit across cancer indications compared to single agents, albeit with increased toxicity. Leveraging the observation that PD-1 and CTLA-4 are co-expressed by tumor-infiltrating lymphocytes, an investigational PD-1 x CTLA-4 bispecific DART molecule, MGD019, is engineered to maximize checkpoint blockade in the tumor microenvironment via enhanced CTLA-4 blockade in a PD-1-binding-dependent manner

    Les bulles « robustes »:Pourquoi il faut construire des logements en région parisienne

    Get PDF
    « Bulle » ou « pas bulle » ? La question taraude les observateurs et les acteurs du marchĂ© immobilier français. Nous examinons dans cet article les Ă©lĂ©ments empiriques et thĂ©oriques qui expliquent la hausse des prix rĂ©cente et sa rĂ©sistance aux retournements conjoncturels. En combinant la notion de bulle Ă©conomique, les arguments de l’économie spatiale et une analyse d’économie politique, nous suggĂ©rons que la valorisation importante de l’immobilier en France est le rĂ©sultat d’une logique rationnelle et conforte les intĂ©rĂȘts des acteurs locaux. DĂšs lors, la forte valorisation peut ĂȘtre considĂ©rĂ©e comme une « bulle robuste », Ă  mĂȘme de rĂ©sister Ă  des chocs importants. Cette bulle organise un transfert intergĂ©nĂ©rationnel et peut avoir des effets positifs. Elle peut Ă©galement renforcer la sĂ©grĂ©gation spatiale, alimenter les inĂ©galitĂ©s territoriales et empĂȘcher d’exploiter les Ă©conomies d’agglomĂ©ration possibles. L’analyse est dĂ©taillĂ©e sur la rĂ©gion Ile-de-France oĂč ces phĂ©nomĂšnes sont particuliĂšrement marquĂ©s

    Updated Higgs cross section at approximate N3LO

    Get PDF
    We update our estimate of the cross section for Higgs production in gluon fusion at next- to-next-to-next-to-leading order (N3LO) in \u3b1s in view of the recent full computation of the result in the soft limit for infinite top mass, which determines a previously unknown constant. We briefly discuss the phenomenological implications. Results are available through the updated version of the ggHiggs code

    Midterm results on a new self-expandable covered stent combined with branched stent grafts: Insights from a multicenter Italian registry

    Get PDF
    Objective: To investigate the technical periprocedural and midterm outcomes of endovascular repairs with multibranched endovascular repair or iliac branch devices combined with a new self-expanding covered stent. Methods: The COvera in BRAnch registry is a physician-initiated, multicenter, ambispective, observational registry (ClinicalTrials.gov Identifier: NCT04598802) enrolling patients receiving a multibranched endovascular repair or iliac branch devices procedure mated with Bard Covera Plus (Tempe, AZ) covered stent, designed to evaluate the outcomes of the covered stent mated with patient-specific and off-the-shelf branched stent graft. Primary end points were technical success, branch instability, and freedom from aortic and branch-related reintervention within 30 days and at follow-up. Preoperative characteristics, comorbidities, and outcomes definitions were graded according to the Society for Vascular Surgery reporting standards. Results: Two hundred eighty-four patients (76 years; range, 70-80 years; 79% males) in 24 centers were enrolled for a total of 708 target vessels treated. The covered stents were mated with an off-the-shelf graft in 556 vessels (79%) and a custom-made graft in 152 (21%). Three hundred seven adjunctive relining stents in 277 vessels (39%) were deployed, of which 116 (38%) were proximal, 66 (21%) intrastent, and 125 (41%) distal. Adjunctive relining stent placement was more frequent when landing in a vessel branch instead of the main trunk (59% vs 39%; P = .031), performing a percutaneous access (49% vs 35%; P < .001), using a stent with a diameter of 8 mm or greater (44% vs 36%; P = .032) and a length of 80 mm or greater (65% vs 55%; P = .005), when a post-dilatation was not performed (45% vs 29%; P < .001) and when an inner branch configuration was used (55% vs 35%; P < .001). Perioperative technical bridging success was 98%. Eight patients (3%) died in the perioperative period. Two deaths (1%) were associated with renal branch occlusion followed by acute kidney injury and paraplegia. Follow-up data were available for 638 vessels (90%) at a median of 32 months (Q1, Q3, 21, 46). Branch instability was reported in 1% of branches. Forty-six patients (17%) died during follow-up, nine (3%) of them owing to aortic-related causes. Primary patency rates at 1, 2, and 3 years were 99% (581/587), 99% (404/411), and 97% (272/279), respectively. Branch instability was associated with patient-specific devices (9% vs 4%; P = .014) and intrastent adjunctive stent placement (12% vs 2%; P = .003), especially when a bare metal balloon-expandable stent was used (25% vs 3%; P < .001). Conclusions: The use of this new self-expanding covered stent mated with branched endografts proved to be safe and feasible with high technical procedural success rates. Low rates of branch instability were observed at midterm follow-up. Comparative studies with other commercially available covered stents are warranted

    High precision determination of the gluon fusion Higgs boson cross-section at the LHC

    Get PDF
    We present the most precise value for the Higgs boson cross-section in the gluon-fusion production mode at the LHC. Our result is based on a perturbative expansion through N3^3LO in QCD, in an effective theory where the top-quark is assumed to be infinitely heavy, while all other Standard Model quarks are massless. We combine this result with QCD corrections to the cross-section where all finite quark-mass effects are included exactly through NLO. In addition, electroweak corrections and the first corrections in the inverse mass of the top-quark are incorporated at three loops. We also investigate the effects of threshold resummation, both in the traditional QCD framework and following a SCET approach, which resums a class of π2\pi^2 contributions to all orders. We assess the uncertainty of the cross-section from missing higher-order corrections due to both perturbative QCD effects beyond N3^3LO and unknown mixed QCD-electroweak effects. In addition, we determine the sensitivity of the cross-section to the choice of parton distribution function (PDF) sets and to the parametric uncertainty in the strong coupling constant and quark masses. For a Higgs mass of mH=125 GeVm_H = 125~{\rm GeV} and an LHC center-of-mass energy of 13 TeV13~{\rm TeV}, our best prediction for the gluon fusion cross-section is \[ \sigma = 48.58\,{\rm pb} {}^{+2.22\, {\rm pb}\, (+4.56\%)}_{-3.27\, {\rm pb}\, (-6.72\%)} \mbox{ (theory)} \pm 1.56 \,{\rm pb}\, (3.20\%) \mbox{ (PDF+αs\alpha_s)} \

    The Peritoneum as a Natural Scaffold for Vascular Regeneration

    Get PDF
    Objective: The peritoneum has the same developmental origin as blood vessels, is highly reactive and poorly thrombogenic. We hypothesize that parietal peritoneum can sustain development and regeneration of new vessels. Methods and Results: The study comprised two experimental approaches. First, to test surgical feasibility and efficacy of the peritoneal vascular autograft, we set up an autologous transplantation procedure in pigs, where a tubularized parietal peritoneal graft was covered with a metal mesh and anastomosed end-to-end in the infrarenal aorta. Second, to dissect the contribution of graft vs host cells to the newly developed vessel wall, we performed human-to-rat peritoneal patch grafting in the abdominal aorta and examined the origin of endothelial and smooth muscle cells. In pig experiments, the graft remodeled to an apparently normal blood vessel, without thrombosis. Histology confirmed arterialization of the graft with complete endothelial coverage and neointimal hyperplasia in the absence of erosion, inflammation or thrombosis. In rats, immunostaining for human mitochondri revealed that endothelial cells and smooth muscle cells rarely were of human origin. Remodeling of the graft was mainly attributable to local cells with no clear evidence of c-kit+ endothelial progenitor cells or c-kit+ resident perivascular progenitor cells. Conclusions: The parietal peritoneum can be feasibly used as a scaffold to sustain the regeneration of blood vessels, whic
    • 

    corecore